计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| O127017-10mg |
10mg |
现货 ![]() |
| |
| O127017-50mg |
50mg |
现货 ![]() |
| |
| O127017-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | TIMAPIPRANT [INN] | 1H-Indole-1-acetic acid, 5-fluoro-2-methyl-3-(2-quinolinylmethyl)- | BCP04237 | [5-Fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-indol-1-yl]acetic acid | Q27247701 | GTPL9277 | 851723-84-7, 950688-14-9 (sodium salt) | A5777 | NCGC00386286- |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | OC000459 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | DP 2 受体拮抗剂 |
| 产品介绍 |
OC000459是一种有效的,选择性的D prostanoid receptor 2 (DP2)(前列腺素受体D2)拮抗剂,IC50为13 nM。 OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist with IC50 of 13 nM. |
| 纯度 | ≥98% |
| ALogP | 4.4 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 2-[5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)indol-1-yl]acetic acid |
| INCHI | 1S/C21H17FN2O2/c1-13-17(11-16-8-6-14-4-2-3-5-19(14)23-16)18-10-15(22)7-9-20(18)24(13)12-21(25)26/h2-10H,11-12H2,1H3,(H,25,26) |
| InChi Key | FATGTHLOZSXOBC-UHFFFAOYSA-N |
| Smiles | CC1=C(C2=C(N1CC(=O)O)C=CC(=C2)F)CC3=NC4=CC=CC=C4C=C3 |
| Isomeric SMILES | CC1=C(C2=C(N1CC(=O)O)C=CC(=C2)F)CC3=NC4=CC=CC=C4C=C3 |
| 关联CAS | 851723-84-7,1422181-22-3 |
| MeSH Entry Terms | (5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid;OC000459 |
| 分子量 | 348.37 |
| Reaxy-Rn | 11693443 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=11693443&ln= |
| 溶解性 | DMSO |
|---|---|
| 分子量 | 348.400 g/mol |
| XLogP3 | 4.400 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 348.127 Da |
| 单同位素质量Monoisotopic Mass | 348.127 Da |
| 拓扑极表面积Topological Polar Surface Area | 55.100 Ų |
| 重原子数Heavy Atom Count | 26 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 516.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 1. Pettipher R, Vinall SL, Xue L, Speight G, Townsend ER, Gazi L, Whelan CJ, Armer RE, Payton MA, Hunter MG. (2012) Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.. J Pharmacol Exp Ther, 340 (2): (473-82). [PMID:22106101] |
| 2. Pettipher R, Hunter MG, Perkins CM, Collins LP, Lewis T, Baillet M, Steiner J, Bell J, Payton MA. (2014) Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.. Allergy, 69 (9): (1223-32). [PMID:24866478] |